Q-omics provides the consensus-scored NDUFB4P7 profile across patient tissues and cancer cell-line models. NDUFB4P7 expression is associated with patient survival in 8 of 34 cancer types, with the highest sampling consensus in KIRP. Additionally, NDUFB4P7 RNA expression shows 2,110 significant pathway-activity associations, with the highest sampling consensus in BRCA. Together, these results highlight KIRP, and BRCA as cancer lineages where NDUFB4P7 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.